Bank Of America Corp Lumos Pharma, Inc. Transaction History
Bank Of America Corp
- $1.12 Trillion
- Q2 2024
A detailed history of Bank Of America Corp transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,800 shares of LUMO stock, worth $6,804. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,800
Previous 1,800
-0.0%
Holding current value
$6,804
Previous $5,000
20.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding LUMO
# of Institutions
40Shares Held
2.17MCall Options Held
0Put Options Held
0-
Wells Fargo & Company San Francisco, CA415KShares$1.57 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY407KShares$1.54 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA244KShares$922,6290.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny216KShares$815,7760.0% of portfolio
-
Acuitas Investments, LLC141KShares$534,6240.19% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $31.7M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...